The recent credit crisis has heightened the awareness of credit risk among financial markets' regulators and participants. However, despite the public discussion on centralized processing systems for the off-exchange traded (Over-The-Counter, OTC) transactions no research has been conducted on the factors that could explain their adoption among market participants. With this study, an attempt is made to cover this gap, in parallel opening the space for further scientific investigation on centralized clearing for OTC derivatives. Based on the Diffusion of Innovation Theory, this first empirical study in the OTC clearing area introduces a model aimed at identifying the drivers and inhibitors for the adoption of an IT-enabled innovation in the form of centralized clearing by the financial organizations. The partial least squares structural equation modeling technique was applied to analyze the results of the survey with the Heads of Clearing/ Operations in various international financial institutions.
INTRODUCTION
Encouraged by increasing use of electronic trading systems in recent years, centralized clearing has established itself as a standard risk mitigation mechanism in the on-exchange traded financial markets. Clearing is understood as the process of calculating the mutual obligations of market participants, usually on a net basis, for the exchange of securities and money (Bank for International Settlements, 2004) . In the recent years of its tremendous growth preceding the credit crisis, the OTC market of privately negotiated derivatives has developed a decentralized, bilateral clearing arrangement characterized by low automation and limited transparency (Bliss and Steigerwald, 2006) . Regulators and policy makers have recognized the potential benefits of centralized clearing for the Over-the-Counter (OTC) derivatives which were blamed for the recent credit crisis and are pushing to clear the privately negotiated transactions through central clearing facilities.
Central counterparty (CCP) clearing is a service performed by a central clearing house. CCP is an entity that interposes itself between counterparties to the financial contracts, becoming the buyer to every seller and seller to every buyer. In this way, the original counterparties to the trade are not exposed to counterparty credit risk of the other party (risk of loss if the counterparty to the trade defaults) but to that of the CCP. Moreover, as the CCP stands between the trading counterparties, multilateral position offsetting is possible (Cecchetti, Gyntelberg, Hollanders, 2009 ).
Central counterparties are structured to manage and mitigate the credit risk of counterparties during the lifetime of the contract (Ripatti, 2004) . The CCP calculates the change in value of the positions of its members on regular basis in order to determine the collateral the members have to post (margin requirement).
A clearing house with its increasing informational and calculative capacity requirement strongly relies on the Information and Communication Technology (Millo, Muniesa, Panurgias and Scott, 2005) . In this context, pricing and calculation of margin requirements for relatively complex OTC derivatives is particularly challenging.
The main focus of this study regards the factors affecting adoption of CCP clearing for OTC derivatives as perceived by sellside 1 market participants. The notion that CCP clearing process is indeed an IT-enabled innovation in the context of the OTC market is the starting point of this study. Mahnke and Overby (2006) define IT-enabled innovation as something that "blends 1 Sell-side encompasses financial institutions (mostly banks) offering trading services to asset managers, hedge funds etc. (Harris, 2003) hardware and/or software assets with business capabilities to generate a novel process, product or service". Up until now most authors have regarded CCP clearing merely as a risk mitigation mechanism. This study sets out to investigate OTC CCP as an IT-enabled innovation, considering this type of post-trade processing system from multiple perspectives.
The study is broken down in three sections: 1) theory and model development, 2) methodology employed to empirically validate the model 3) discussion of the research findings and their implications.
THEORY AND MODEL DEVELOPMENT
The conceptual background of the presented model creates the Diffusion of Innovation (DOI) theory with the innovation attributes as factors that facilitate or hinder innovation adoption (Figure 1 ). In Rogers' theory (Rogers, 1995) an innovation is defined as "an idea, practice, or object that is perceived as new by an individual or other unit of adoption". According to Roger's classification, a CCP is considered as preventive innovation, "a new idea that requires action at one point in time in order to avoid unwanted consequences at some future time" (Rogers, 2002) . The role of a CCP clearing arrangement is to minimize the losses to its members after a participant's default using a predefined loss-sharing mechanism (Wendt, 2006 
Figure 1 Research model
One of the main focuses of DOI are the characteristics of an innovation which may influence its adoption. Whereas in the original work of Rogers five such attributes are identified as to significantly influence the adoption decision, other authors expanded the list by further characteristics (e.g. Benbasat, 1991). Nevertheless, Tornatzky and Klein's (1982) meta-analysis of 75 studies showed that from several identified innovation attributes, only three: relative advantage, compatibility, and complexity had in the most cases the significant relationship to innovation adoption. Therefore, in this study the set of constructs from DOI related to innovation characteristics will be limited to three.
Conceptualization of the Innovation Attributes
"Relative advantage" in the presented model is in accordance with existing DOI literature and refers to: the "degree to which an innovation is perceived as being better than the idea it supersedes'" (Rogers, 2002) . In case of CCP clearing for OTC derivatives the comparison base is the bilateral clearing process. Relative advantage is conceptualized as multidimensional aggregate second order construct with three sub-constructs referring to different aspects of CCP's potential advantages: processing efficiency, capital efficiency and counterparty credit risk mitigation.
H1
A higher level of perceived relative advantage (measured by processing-, capital-and risk mitigation efficiency) leads to a stronger adoption of CCP clearing for OTC derivatives.
The conceptualizations of compatibility in this study takes into account its operational aspects understood as fit with existing practices, routines and infrastructure rather than individual values. This approach corresponds to reality of new process implementation within an institution. As the integration of OTC CCP may require substantial changes in the internal processes, operational compatibility may play a significant role in taking adoption decisions.
H2
A higher level of perceived compatibility leads to a stronger adoption of CCP clearing for OTC derivatives.
A productive system is complex if it consists of numerous elements and those elements interact with one another richly (Rivkin, 2001) . Complexity refers in this study to CCP specific processes spurred by daily margining and their cost (Wendt, 2006) .
H3
A higher level of perceived complexity leads to a weaker adoption of CCP clearing for OTC derivatives.
Conceptualization of Context Variables
Although DOI has proven to be a viable framework for examining adoption of innovation (Dwivedi, Williams, Lal, Schwarz, 2008) , it is necessary to incorporate additional factors that help in explaining contextual effects.
Critical mass construct is an extension to traditional framework of DOI. Fichman (1992) recognizes lacking consideration of adopters' interdependencies as a substantial limitation of classic diffusion model. When an innovation is subject to network externalities, like in case of clearing (Pirrong, 2009 ), achieving critical mass of market participants who want to adopt the innovation becomes crucial. If critical mass is achieved the innovation is likely to be universally adopted, otherwise it will be probably abandoned (Markus, 1987) .
H4
Achieving critical mass of market participant willing to support implementation of OTC CCP influences positively the adoption of CCP clearing for OTC derivatives.
In case of CCP the key moderator is product standardization. According to Chin, Marcolin and Newsted (1996) : "The moderator affects the direction and/or strength of the relation between an independent or predictor variable and a dependent or criterion variable". In case of product standardization the moderating effect is expected to influence the relation between endogenous variable-CCP adoption-and its predictors-relative advantage and compatibility.
Due to the recent improvements in automation of the post-trade infrastructure for electronic eligible OTC derivatives, the relative advantage of CCP innovation may be conceived to be higher for highly customized rather than standardized products. Therefore, it is argued that for the standardized products, the influence of the relative advantage on OTC CCP adoption is weakening.
H5
The higher a degree of product standardization the weaker the influence of relative advantage on adoption of CCP clearing for OTC derivatives.
Conversely, a strengthening effect of product standardization on relation between compatibility and adoption is hypothesized. Some elements of existing global infrastructure (electronic trade confirmation platforms, trade information warehouse) may still be utilized as complementary to OTC CCP process which may ease the implementation efforts.
H6
The higher a degree of product standardization the stronger the influence of compatibility on adoption of CCP clearing for OTC derivatives.
The instrument standardization level is defined by three product group features based on existing literature: 1) market commonality of instrument terms and conditions (Bank for International Settlements, 2007), 2) existence of valuation model accepted by majority of market participants (ibidem), 3) level of profit margins for dealers the product group brings (Tabb and Iati, 2009 ).
Moreover, the positive direct influence of product standardization on adoption is hypothesized as the standardization is a basic requirement for centralized trade processing within a clearing house.
H7
The higher a degree of product standardization the stronger the adoption of CCP clearing for OTC derivatives (direct influence).
Adoption Construct
The traditional DOI framework has its limitation. It tends to neglect the realities of implementing technological innovations within organizations, where the decision to adopt the new technology is made at the organization or division level rather than by the individual user. Sullivan (2006) refers to these conditions of non-voluntary adoption as to a "contingent authority adoption decision" meaning that "an authority makes initial decision to adopt and mandates adoption/use of new technology by the targeted users".
The endogenous variable was adjusted in order to cater for the organizational character of this research. For the purpose of evaluating the construct both actual usage and intention of the future usage of OTC CCP by organizations have been employed. Adopters may make a binary decision to adopt or reject, or may choose differing levels of CCP usage (Bayer and Melone, 1989) . Concerning adoption alone, a binary variable is applied based on whether an organization uses/is a member of OTC CCP or not. Moreover, the intensity measure defined as percentage of eligible trades cleared centrally is used.
RESEARCH METHOD
Due to lack of sources on factors affecting adoption of clearing arrangements, the items were developed by the author and tested in interviews with four clearing experts. The objective was to verify the convergent and discriminant validity of the scales by examining how the items were sorted into various construct categories. (Davis, 1989) The judges were asked to rank how well the items fit the construct definitions and then asked to assign items to specific constructs. Moreover, they were requested to assess the item's wording. Based on expert assessment of the items' wording and content, in several cases, item formulation was improved and one item shifted between constructs.
The scale was developed as reflective since it was assumed that for all items "a change in the latent variable causes variation in all measures simultaneously; furthermore, all measures in a reflective measurement model are positively intercorrelated" (Diamantopoulos, Riefler, Roth, 2008) .
Data Collection and Analysis
Survey data was collected by means of an e-mail questionnaire. In order to assess and refine the form, the instrument was pre-tested with a mail pilot with 20 Heads of Clearing/ Operations from the sell-side institutions. Questions were rearranged to reduce the potential ceiling and floor effect that may induce monotonous responses from participants. Moreover, the scale consists of some items that are worded in opposite directions to alleviate response biases; prior to statistical data analysis the reverse scored items were recoded.
In total, the sample of 256 respondents was approached by phone to participate via e-mail and promised a copy of the results. The sample encompassed the largest international sell-side institutions active in the OTC market and was derived from Capital Market Association database and personal contacts. For organizational perspective of this research (only) one of the following respondents within each company was invited to take part in the survey: Head of (OTC) Operations or Head of Clearing. The respondents who agreed in a phone call to take part in a survey received an e-mail questionnaire. Despite the pre-selection, 8 of the contacted persons admitted to have no experience with CCPs and, therefore, were not able to answer the questionnaire. Four weeks after the initial mailing the non-respondents were sent a follow up e-mail. A resulting sample of 248 respondents was collected, all of which had enough knowledge regarding the specific questions on OTC CCP subject. Overall, 53 completed questionnaires were received, which corresponds to 21 % response rate. Addressing the questionnaire to management level professionals with experience in OTC clearing has made it difficult to reach a higher response rate as, in most companies only one contact person was available. However, the sample size fulfilled the requirements imposed by model specification. Early and late respondent analysis was conducted (Armstrong and Overton, 1977) . T-test for independent samples of early and late respondents provided evidence that non-response bias does not affect significantly the study results.
The partial least squares (PLS) approach was employed to estimate both the measurement and the structural parameters in the structural equation modeling approach. The PLS is considered to be the most appropriate analysis technique for the current study as it supports exploratory research and places minimum requirements on sample size (Chin, 1998) .
Missing values represent a challenge if they substantially reduce the number of available cases. According to Schafer and Graham (2002) , "If a missing-data problem can be resolved by discarding only a small part of the sample, then the method (case deletion) can be quite effective". In this study, missing data represented only 0.9 % of responses and for the reasons outlined above casewise deletion was used to handle them.
Item Question

AD1 We use CCP clearing for eligible OTC derivatives trades. (binary)
AD2 We are members of CCP clearing facility for OTC derivatives. (binary)
AD3 What percentage of eligible OTC derivatives trades do you clear centrally by CCP? (1-"100-85%" to 5-"15-0%")
AD4
Given that OTC CCP facility is available I would recommend the executives in our company to use CCP clearing for OTC derivatives we trade.
AD5 I intend to actively support implementation of CCP facility for OTC derivatives in my organization.
AD6 Assuming that my company can have access to the CCP clearing for OTC derivatives I think that we should use it.
CX1 Overall collateral requirement of OTC CCP has to be higher than that while clearing on bilateral basis.
CX2
The margin requirement of OTC CCP is … in comparison to average collateral paid in the OTC market.
(1-"very high" to 5-"very low") CM1 Our company would support creation of OTC CCP clearing only if other large market participants support it too.
CM2
Our company would support creation of OTC CCP clearing only after most active derivatives dealers had expressed their commitment to do it.
CM3 Due to their large trading volume, the dealer support is mandatory to create OTC CCP.
CO1 OTC CCP clearing is not compatible with our work practice (reverse scored).
CO2 I think that it would be easy to integrate CCP process in the internal processes in our company.
CO3 Usage of OTC CCP is consistent with our experience for on-exchange trades.
DS1
The most eligible OTC derivatives products for CCP clearing are ...a) those for which a broadly accepted valuation models exist.
DS2 b)... those with relative low profit margins for dealers.
DS3 c)…those with relative highly standardized terms and conditions. DS4 CCP clearing is not applicable for exotic OTC derivatives due to relative low standardization of their terms and conditions. DS5 Using CCP for clearing standardized OTC trades is more reasonable than for exotic trades.
RC1 CCP clearing will enable us to employ our capital for higher margin products.
RC2 Usage of OTC CCP would enable us to enlarge our business as it frees up credit lines.
RM1 OTC CCP clearing could decrease counterparty credit risk exposure more than other bilateral OTC risk mitigation mechanisms. RP3 c)...OTC CCP has a potential to improve correctness and completeness of data. The research model (figure 1) was tested using SmartPLS software Version 2.0 (Ringle, Wende, Will, 2005). As the software allows to measure latent multidimensional variables by repeated indicators and maximizes variance explained it considered to fit the nature of this study. The indicators presented in table 1 were used to measure the latent variables. The Lickert type 5 item scale with a neutral middle was employed and adapted for the current context. Additionally, a binary variable was used to measure two items of adoption. All indicators and constructs were operationalized using a reflective mode. The dimensions of relative advantage i.e. processing efficiency, counterparty risk mitigation and capital efficiency were aggregated to second order constructs.
The results will be interpreted in two stages: first, the measurement model and then the structural model. Evaluation of the measurement model is based on evaluation of the item loadings, reliability of scales and the constructs' discriminant validity. According to Chin (1998) , each factor loading should be greater than 0.707 in order to share more variance with the component score than with error variance. However, loadings of 0.60 are also acceptable in the early stage of measures development and if additional indicators exist in the block for comparison basis (Hulland, 1999) . In this research only one indicator (CX3) loaded under 0.6 and was dropped. Two items of adoption constructs loaded under 0.707 but still with high and acceptable values of 0.701 and were kept in the model (eliminating these indicators might change the domain of the adoption construct). The individual item loadings for the rest of the constructs exceeded 0.707 (table 2) . In case of multi item constructs (which is the case in this study) the composite reliability should be tested (Hulland, 1999) . All the reflective constructs had a composite reliability above 0.89. Hence, they were above the recommended 0.70 level (Chin et al., 1996) suggesting internal consistency. The convergent validity for the reflective constructs was also confirmed, as the average variance extracted (AVE) was above the guideline of 0.5 (Chin, 1998) . Barclay et al. (1995) suggest that no manifest variable should load higher on other constructs than on the construct it intends to measure. Results of the cross-loading analysis showed that all items load higher on their respective intended latent variable compared to other latent variables. 2 Therefore, discriminant validity at the indicator level is ensured. Figure 2 shows all the path coefficients, significance levels and variance explained in the research model. The requirements regarding paths coefficients in the structural model of more than 0.1 (Sellin and Keeves, 1994) are fulfilled for all structural relationships except the relationship between complexity and adoption construct. Bootstrap method with 500 samples was used to assess the statistical significance of the path coefficients. The paths between complexity and adoption as well as moderating effect of product standardization on relation between compatibility and adoption lack the significance. Further paths were significant. The R-squared value for the dependent variable indicates that the model explained variance accounts for 52,5 % which is seen as an average (Chin et al., 1996) . The Stone-Geisser's Q 2 was calculated using the blindfolding cross-validation method. The test criterion values exceed zero which confirms predictive relevance of the model (Chin, 1998) . Discriminate validity of the model has been confirmed as the diagonal elements (square root of AVE) are significantly higher than off the diagonal values (representing correlation between constructs) in the corresponding rows and columns. The hypotheses of the influence of complexity on adoption was rejected as well as the moderating effect of product standardization on relation between compatibility and adoption. The linkages corresponding to rejected hypotheses were dropped, and the PLS model was re-estimated. The analysis revealed that the beta coefficients and t-values of the remaining model were strong and significant. In addition, the R-squared value changed only slightly (54,5%), which manifests the statistical validity of the remaining linkages.
Measurement Model Evaluation
Structural Model Evaluation
DISCUSSION OF RESEARCH FINDINGS AND IMPLICATIONS
Based on DOI framework, this study explored the adoption of Central Counterparty clearing as an innovative IT-enabled system in the OTC market and identified the influential and impeding factors.
The empirical analysis confirmed that perceived relative advantage of the OTC CCP and compatibility with existing posttrade processes contribute substantially to adoption of centralized clearing for OTC derivatives, whereas complexity does not appear to be an important predictor. All three dimensions of relative advantage as well as aggregate second order construct exhibit strong influence on OTC CCP adoption. Critical mass was confirmed as having strong direct influence on OTC CCP adoption. Product standardization was found to have both strong direct influence on OTC CCP adoption as well as to moderate the relationship between relative advantage and adoption. However, the strengthening effect of the latter on the linkage between compatibility and adoption was not significant.
The findings are in line with the observations on the CCPs' diffusion in the OTC derivatives market. As the market participants had made high investments in the post-trade processing solutions and connections to global infrastructure in the past years, the operational compatibility between current processing of OTC derivatives and CCP service seems essential. An accelerated OTC CCP adoption has been observed after the turmoil caused by the sub-prime crisis. This may be explained by an increase in perceived relative advantage of OTC CCP-mostly on counterparty credit risk level. The complexity of the OTC CCP was not found in this study to influence the adoption willingness as expected. The explanation may be a perceived relative low margin requirement within CCP resulting from increasing competition within clearing sector or/and increasing use of collateral in the bilateral post-trade processing. Critical mass was found to directly influence CCP adoption. Due to economies of scale existent in clearing, achieving critical mass of market participants and volumes cleared makes the OTC CCP adoption dependent on the largest derivatives dealers. Product customization impedes automation of post-trade processing; lack of a commonly accepted valuation model makes risk management difficult. Therefore, standardization is a requirement for effective CCP clearing.
This study adds to the base of knowledge concerning clearing arrangements and provides several groups of stakeholders (including clearing houses and regulatory bodies) with valuable information about the factors influencing adoption of OTC CCPs. Despite the public discussion on CCP clearing for OTC derivatives no empirical research has been conducted on the factors that might explain CCP adoption among market participants. With this study, an attempt is made to cover this gap, in parallel opening the space for further scientific research on OTC CCPs.
Some limitations of the presented study will be highlighted below in order to formulate implications for future research. The used sample size of 53 is adequate for an exploratory investigation as in the presented study, but larger sized samples are required for future confirmatory research. The development of a more rigorous model with formative scales (focusing on causes of CCP efficiency) might further improve the variance explained.
This research raises several fields of interest for further investigation. This work is the first that empirically explores the OTC CCP process adoption. Up until now most authors have regarded CCP merely as a risk mitigation mechanism, ignoring the potential impact of this post-trade system on operational risk as well its capital efficiency implications. It is suggested that these factors be considered in future research and their meaning for the effective development of a market infrastructure investigated. As the focus of the study lies at perceptions of sell-side market participants regarding OTC CCP adoption, the public cost/benefit perspective was neglected. However, one possible research direction is to investigate the regulatory pressure as one of the factors influencing OTC CCP adoption if considered in a public context.
